Audit 322206

FY End
2023-12-31
Total Expended
$1.21M
Findings
0
Programs
2
Year: 2023 Accepted: 2024-09-30

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
95.006 Model Acts Program $1.19M Yes 0
16.838 Comprehensive Opioid, Stimulant, and Other Substances Use Program $15,309 - 0

Contacts

Name Title Type
G1NMA2GL72D7 Jasmine Dale Auditee
4342523300 Clarissa Hoffman Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Organization has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of LEGISLATIVE ANALYSIS AND PUBLIC POLICY ASSOCIATION for the year ended December 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U. S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Organization, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Organization.